Galectin Therapeutics (GALT)

• Market cap: $72.2M
• 1 day: 3.60%
• 5 days: -4.17%
• 1 month: -50.22%
• 3 months: -56.27%
• 6 months: -51.68%
• Year to date: -1.71%
• 1 year: -36.81%
• 5 years: -60.21%
• 10 years: -67.61%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

21% more capital invested

Capital invested by funds: $22.2M [Q2] → $26.9M (+$4.72M) [Q3]

8% more funds holding

Funds holding: 73 [Q2] → 79 (+6) [Q3]

0.03% more ownership

Funds ownership: 15.7% [Q2] → 15.73% (+0.03%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 19

29% less call options, than puts

Call options by funds: $3.89M | Put options by funds: $5.46M